Cayuga is developing novel biomimetic therapies leveraging inorganic polyphosphate, a polymer that modulates the healing response. The company has an optimized polyP-SNP complex in late preclinical development for the treatment of acute major hemorrhage, a discovery-stage novel composition for the treatment of inherited bleeding disorders, as well as a portfolio of early-stage programs focused across the healing continuum. To learn more, please visit www.CayugaBiotech.com.
Company Details
- Employees
- 9
- Address
- New York And Massachusetts, Us
- Industry
- Biotechnology
- Website
- http://www.cayugabiotech.com
- Keywords
- biotechnology, pharmaceuticals, hematology, coagulation, postpartum hemorrhage, trauma, blood thinner bleeding, surgery, hemophilia, thrombocytopenia, rare bleeding, hemostasis, surgical bleeding, gastrointestinal hemorrhage.
- HQ
- New York and Massachusetts
Cayuga Biotech Questions
Cayuga Biotech's website is http://www.cayugabiotech.com
Cayuga Biotech's LinkedIn profile is https://www.linkedin.com/company/cayuga-biotech
Cayuga Biotech has
9 employees.
View email and phone details for 9
employees at Cayuga Biotech.
Cayuga Biotech's industry is
Biotechnology
Cayuga Biotech's top competitors are
Wayfinder Biosciences,
Lavaage,
Resilience,
Cpsi Biotech,
Nelum Corp,
Highfield Biopharmaceuticals,
Aquasyn Llc,
Lfb Sa Laiterie Fromagerie Bourrignon Sa,
Cygenica Ltd.,
Epm Group Consulting.
Cayuga Biotech's categories are Biotechnology
